Delivery Order SPE2DB22D3016-SPE2DB25FADM4

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $2.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,987.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order, involves the supply of APONVIE 32 MG/4.4 ML VIAL 4.4ML, a pharmaceutical product, with a firm fixed-price pricing type and an ultimate completion date of January 15, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,684.93 and provides for the delivery of an injectable pharmaceutical product, APONVIE 32 MG/4.4 ML VIAL 4.4ML, to support military healthcare programs. The contract is a firm fixed-price instrument with a completion date of February 4, 2025. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,845.41, is a delivery order under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, worth up to $999,999,999.00 through November 2026. The contract covers the delivery of a wide range of pharmaceutical products and medical supplies, including...
This federal contract award, valued at $16,786.32, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999 and running through November 2026. The contract covers the procurement of a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and...
This federal contract award, valued at $1,761.15, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen, valued at $999,999,999 and running through November 2026. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies,...
This federal contract award, valued at $25,731.31, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. The award covers the provision of a wide range of pharmaceutical products and medical...
This federal contract award, with a ceiling value of $4,157.52, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The contract covers a broad range of medical commodities, including specialty medications, brand-name...
This federal contract award, valued at $3,223.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,291.91, is a Delivery Order issued under an Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of $999,999,999 and runs through November 2026. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical...
This is a federal contract award made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,654.62, is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, worth $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FADM4
    Delivery Order

The federal contract award, SPE2DB22D3016|SPE2DB25FADM4, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,891.26, is for the delivery of APONVIE 32 MG/4.4 ML VIAL 4.4ML medical products.

This contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract includes critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract award does not have a set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and there is no information provided about any subcontractors. The DLA, a defense agency, is the funding agency for this contract, which aligns with its mission to support the healthcare needs of military personnel and veterans.

Generated 5/20/25, 2:20 PM